Mortality in pediatric oncology and stem cell transplant patients with bloodstream infections
BackgroundBloodstream infections (BSI) continue to represent a significant source of morbidity for pediatric oncology patients, however less is known regarding this population’s risk of death. We sought to evaluate the risk of BSI and death at a large pediatric cancer center.MethodsWe retrospectivel...
Main Authors: | Daniel N. Willis, Mary Claire McGlynn, Patrick J. Reich, Robert J. Hayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1063253/full |
Similar Items
-
Antibiotic Resistant Bloodstream Infections in Pediatric Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant: Factors Associated with Development of Resistance, Intensive Care Admission and Mortality
by: Elio Castagnola, et al.
Published: (2021-03-01) -
High morbidity and mortality associated with primary bloodstream infections among pediatric patients with cancer at a Guatemalan tertiary referral hospital
by: Sheena Mukkada, et al.
Published: (2022-11-01) -
Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation Recipients
by: Chen W, et al.
Published: (2022-11-01) -
Nurse-Driven Interventions Reduce Central Line-Associated Bloodstream Infection Close to Zero in One Pediatric Oncologic Facility: A Single-Center Retrospective Observational Study
by: Federico Turoldo, et al.
Published: (2024-09-01) -
The epidemiology of pediatric oncology and hematopoietic cell transplant admissions to U.S. intensive care units from 2001-2019
by: Kyle B. Lenz, et al.
Published: (2024-12-01)